Intended for healthcare professionals

News

Pfizer loses appeal over use of branded painkiller pregabalin

BMJ 2016; 355 doi: https://doi.org/10.1136/bmj.i5578 (Published 17 October 2016) Cite this as: BMJ 2016;355:i5578